Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.

已完结 10 由 Aixuexi 发布于 2025/12/22 14:27:26

DOI:10.1056/NEJMoa2508668
作者：Sara M Tolaney,?Zefei Jiang,?Qingyuan Zhang,?Romualdo Barroso-Sousa,?Yeon Hee Park,?Mothaffar F Rimawi,?Cristina Saura,?Andreas Schneeweiss,?Masakazu Toi,?Yee Soo Chae,?Yasemin Kemal,?Mukesh Chaudhari
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Trastuzumab deruxtecan has shown efficacy in patients with previously treated human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer. The e

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierExplainable machine learning-guided design of high-performance thermoelectric materials